Novel, Linkable TGF-b Inhibitor Payload Selectively & Safely Blocks Fibrotic Disease & Immune Suppression in Cancer Patients
- Leveraging small-format and peptide conjugates for BBB penetration
- Assessing preclinical models for neuro-targeted delivery
- Evaluating payload compatibility for CNS indications